Literature DB >> 15517089

Neuropsychological rehabilitation of memory deficits and activities of daily living in patients with Alzheimer's disease: a pilot study.

R Avila1, C M C Bottino, I A M Carvalho, C B Santos, C Seral, E C Miotto.   

Abstract

Patients with Alzheimer's disease (AD) gradually lose their cognitive competence, particularly memory, and the ability to perform daily life tasks. Neuropsychological rehabilitation is used to improve cognitive functions by facilitating memory performance through the use of external aids and internal strategies. The effect of neuropsychological rehabilitation through memory training - motor movements, verbal association, and categorization - and activities of daily living (ADL) training was tested in a sample of 5 elderly out-patients (mean age: 77.4 +/- 2.88 years), with mild AD (Mini-Mental State Examination score: 22.20 +/- 2.17) and their caregivers. All patients had been taking rivastigmine (6-12 mg/day) for at least 3 months before being assigned to the rehabilitation sessions, and they continued to take the medication during the whole program. Just before and after the 14-week neuropsychological rehabilitation program all patients were assessed by interviewers that did not participate in the cognitive training, using the Mini-Mental State Examination, Montgomery-Alsberg Depression Rating Scale, Hamilton Anxiety Scale, Interview to Determine Deterioration in Functioning in Dementia, Functional Test, Memory Questionnaire of Daily Living for patient and caregiver, Quality of Life Questionnaire for patient and caregiver, and a neuropsychological battery. The results showed a statistically significant improvement in ADL measured by Functional Test (P = 0.04), and only a small improvement in memory and psychiatric symptoms. Our results support the view that weekly stimulation of memory and training of ADL is believed to be of great value in AD treatment, not only delaying the progress of the disease, but also improving some cognitive functions and ADL, even though AD is a progressively degenerative disease.

Entities:  

Mesh:

Year:  2004        PMID: 15517089     DOI: 10.1590/s0100-879x2004001100018

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  12 in total

1.  Adjunctive cognitive remediation for schizophrenia using yoga: an open, non-randomized trial.

Authors:  Triptish Bhatia; Akhilesh Agarwal; Gyandeepak Shah; Joel Wood; Jan Richard; Raquel E Gur; Ruben C Gur; Vishwajit L Nimgaonkar; Sati Mazumdar; Smita N Deshpande
Journal:  Acta Neuropsychiatr       Date:  2011-08-10       Impact factor: 3.403

Review 2.  Added therapeutic value of memantine in the treatment of moderate to severe Alzheimer's disease.

Authors:  T Heinen-Kammerer; H Rulhoff; S Nelles; R Rychlik
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 3.  Cognitive rehabilitation therapies for Alzheimer's disease: a review of methods to improve treatment engagement and self-efficacy.

Authors:  Jimmy Choi; Elizabeth W Twamley
Journal:  Neuropsychol Rev       Date:  2013-02-12       Impact factor: 7.444

4.  Effects of a multidisciplinary cognitive rehabilitation program for patients with mild Alzheimer's disease.

Authors:  Luciane F Viola; Paula V Nunes; Monica S Yassuda; Ivan Aprahamian; Franklin S Santos; Glenda D Santos; Paula S Brum; Sheila M Borges; Alexandra M Oliveira; Gisele F S Chaves; Eliane C Ciasca; Rita C R Ferreira; Vanessa J R de Paula; Oswaldo H Takeda; Roberta M Mirandez; Ricky Watari; Deusivania V S Falcao; Meire Cachioni; Orestes V Forlenza
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 5.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

6.  Conditioning training and retrieval increase phospholipase A(2) activity in the cerebral cortex of rats.

Authors:  E L Schaeffer; L Zorrón Pu; D A M Gagliotti; W F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2008-11-04       Impact factor: 3.575

7.  Computer-based cognitive training for mild cognitive impairment: results from a pilot randomized, controlled trial.

Authors:  Deborah E Barnes; Kristine Yaffe; Nataliya Belfor; William J Jagust; Charles DeCarli; Bruce R Reed; Joel H Kramer
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

8.  Short-term environmental enrichment rescues adult neurogenesis and memory deficits in APP(Sw,Ind) transgenic mice.

Authors:  Jorge Valero; Judit España; Arnaldo Parra-Damas; Elsa Martín; José Rodríguez-Álvarez; Carlos A Saura
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

9.  Neuroprotection against vascular dementia after acupuncture combined with donepezil hydrochloride: P300 event related potential.

Authors:  Qiang Liu; Xiu-Juan Wang; Zhe-Cheng Zhang; Rong Xue; Ping Li; Bo Li
Journal:  Neural Regen Res       Date:  2016-03       Impact factor: 5.135

10.  Group Intensive Cognitive Activation in Patients with Major or Mild Neurocognitive Disorder.

Authors:  Simonetta Panerai; Domenica Tasca; Sabrina Musso; Valentina Catania; Federica Ruggeri; Alberto Raggi; Stefano Muratore; Giuseppina Prestianni; Cinzia Bonforte; Raffaele Ferri
Journal:  Front Behav Neurosci       Date:  2016-02-29       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.